Further, a significant increase in IFN-γ+IL-2+ double cytokine production by both tumor-infiltrating CD8+and CD4+ was obtained in the Lm-LLO-CD105A treated group in comparison to the Control Lm treated group (Figures 4C, F). The gene discussed is IL2; the disease is neoplasm.